Klinavo
Request Demo
verifiedThe Intelligent CRO CRM

From Biotech Signals to CRO Revenue.
Automated.

The only platform that visualizes biotech pipelines, predicts CRO service needs, and connects you to the right clinical leads.

Start Scaling Your CROarrow_forwardView Platform Tour
TRUSTED BY TEAMS AT:
PHARMAXGENE.SYSBIO_LOGIC

Klinavo Connect

Monitor drug development cycles across 15,000+ biotech startups. Our AI identifies exactly where a drug sits in the regulatory path before they even post an RFP.

biotech

Discovery

Target ID
science

Pre-Clinical

In-Vivo Testing
High Probability CRO Need
notifications_active

IND Filing

Trigger Detected
group

Phase I

Safety
clinical_notes

Phase II

Efficacy

Predictive Service Triggers

Our algorithms scan 8-K filings, patent updates, and clinical registries to alert you when a prospect is ready for your specific services.

Explore all triggersopen_in_new
warning

Regulatory Gap Detected

Identified missing toxicology data for 'TheraGene' prior to their EMA filing. Potential for safety study services.

IMMEDIATE ACTION
trending_up

IND-Enabling Phase

3 compounds at 'Helix Bio' moved to pre-IND status within 48 hours. Mass outsourcing expected for Phase I preparation.

HIGH CONVERSION
payments

Capital Inflow Spike

'Nova Vax' secured $85M Series C. Direct correlation with Clinical Trial Management System (CTMS) procurement.

BUDGET LOCKED

Market Movements

Real-time feed of the signals that matter. We filter out the noise and deliver actionable market intelligence for CRO growth teams.

analyticsMarket Sentiment

Oncology Outsourcing+12.4%
Rare Disease R&D+8.1%
receipt_long
FUNDING2 MINUTES AGO

Verve Therapeutics closes $120M IPO to advance gene-editing pipeline.

Expected increase in manufacturing and Phase III logistics requirements.

description
FDA UPDATE1 HOUR AGO

FDA grants Fast Track designation to Alkeus Pharmaceuticals for ALK-001.

Accelerated timeline suggests early procurement of regulatory consulting.

language
TRIAL LAUNCH3 HOURS AGO

Beam Therapeutics initiates patient dosing in BEACON Phase 1/2 trial.

Global site monitoring and patient recruitment services needed for EU expansion.

Ready to dominate the
clinical trial market?

Join elite CRO business development teams using Klinavo to identify high-value opportunities before the competition.

Start Scaling Your CROSpeak to an Expert

No credit card required. Personalized 14-day data pilot included.